AtoZ-CRO GmbH from Germany and Abundnz B.V. will work in partnership for phase 0 micro dose studies. AtoZ-CRO is a full-service Clinical Research Organization with over 30 years of experience in Phase I – IV clinical studies.
Other partnerships with Abundnz.
Abundnz has partnerships with ImMunoSysLtd, IBIS Technologies, MsMetrix, Van Sonsbeek Software, InnoTherapy and Ducares.